comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 15:29:33 - browse：542

President Joe Biden talks in the Roosevelt Room of the White House, in front of a painting of Theodore Roosevelt on a horse back — politics coverage from STAT — President Biden MANDEL NGAN/AFP via Getty Images

WASHINGTON — The White House is throwing its support behind a controversial authority that allows the government to undermine patent rights for certain high-priced medicines. It’s an early step that could have major ramifications for the American pharmaceutical industry, depending on whether and how federal officials actually use the authority.

The administration issued a framework for the National Institutes of Health to more broadly use so-called “march-in rights” — a policy that allows it to invalidate patent rights from drugmakers whose products rely on federally funded research. The framework lays out when the agency might assert this authority, and endorse using a drug’s price in that determination.

“We’ll make clear that when drug companies won’t sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House National Economic Advisor Lael Brainard told reporters. “These authorities are in existing laws, the last administration just didn’t want to allow them to be used in this way.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Biden White House, tech companies launch new safeguards around emerging AI technology

focus

WSS

ARCH Venture Partners is raising $3 billion for a life sciences fund

What we need to know about Arena Bioworks

Vertigo drug brings hope for rare neuron disorder, Niemann

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Why the advice to take all your antibiotics may be wrong

New chart reveals military’s vast involvement in Operation Warp Speed

hotspot

comprehensive

focus

Alkermes shareholders re

Hey, doctors: Don't be no

Hollywood unions extend contract negotiations for actors

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

23andMe had bad news about my health. I wish a person had delivered it

Why the advice to take all your antibiotics may be wrong

Walensky prepares to leave CDC — and Congress — behind

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

New air purifier tech could be key to improving indoor air quality

The lessons of Aduhelm, an Alzheimer's drug that was not to be

focus

Hey, doctors: Don't be no

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

A new deal aims to ramp up use of AI in rehab care decisions

New chart reveals military’s vast involvement in Operation Warp Speed

Juul spent big to court Black leaders to promote its e

What we need to know about Arena Bioworks

knowledge

Wikipedia

focus

entertainment